Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026)
Apyx Medical (APYX) posted Cash from Financing Activities of $83000.0 for Q1 2026, down 99.12% on a QoQ basis from $9.5 million in Q4 2025, and up 232.0% year-over-year from $25000.0 in Q1 2025.
Apyx Medical (APYX) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Apyx Medical's Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $83000.0 for Q1 2026.
- Quarterly Cash from Financing Activities rose 232.0% year-over-year to $83000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 42.26% YoY) and the FY2025 annual result came in at $9.6 million, up 42.03% from the prior year.
- Cash from Financing Activities was $83000.0 for Q1 2026 at Apyx Medical, down from $9.5 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $23.8 million in Q4 2023 and bottomed at -$10000.0 in Q4 2022.
- A 5-year average of $2.9 million and a median of $46000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities soared 238540.0% — and 2024, when it tumbled 110.87%.
- Apyx Medical's Cash from Financing Activities stood at -$10000.0 in 2022, then surged by 238540.0% to $23.8 million in 2023, then sank by 71.65% to $6.8 million in 2024, then surged by 40.31% to $9.5 million in 2025, then plunged by 99.12% to $83000.0 in 2026.
- Business Quant data shows APYX's Cash from Financing Activities at $83000.0 in Q1 2026, $9.5 million in Q4 2025, and $45000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Apyx Medical | 167.53 Mn | 136.65 Mn | 7.93 Mn | 83,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 9.49 Mn |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 6.76 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 30, 2024 | -5,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 23.84 Mn |
| Dec 31, 2023 | 23.84 Mn |